The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,250.00
Bid: 2,220.00
Ask: 2,280.00
Change: 10.00 (0.45%)
Spread: 60.00 (2.703%)
Open: 2,255.00
High: 2,255.00
Low: 2,250.00
Prev. Close: 2,240.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of SAYE Options, Director Dealing & TVR

1 Nov 2023 14:38

RNS Number : 0859S
Craneware plc
01 November 2023
 

Craneware plc

("Craneware" or the "Company")

 

Exercise of SAYE Options, Director Dealing

and Total Voting Rights

 

1 November 2023 - The Board of Craneware plc (AIM: CRW.L), the market leader in automated Value Cycle solutions for the US healthcare market, announces that on 31 October 2023, options over ordinary shares of 1p each in the Company ("Ordinary Shares") were exercised under the terms of the Craneware plc SAYE Option Plan (2018) by certain employees and Directors (the "SAYE Options" and together, the "Exercise").

 

Included within the Exercise was an aggregate of 3,136 SAYE Options exercised by the following Directors:

 

Director

Number of SAYE Options exercised

Exercise price

(per Ordinary Share)

SAYE Options as a percentage of total voting rights of the Company

 

Keith Neilson (CEO)

 

1,568

 

1,147.5 pence

 

0.004%

 

Craig Preston (CFO)

 

1,568

 

1,147.5 pence

 

0.004%

 

Following this transaction, Keith Neilson holds 3,467,707 Ordinary Shares, representing 9.81% of the total voting rights of the Company and Craig Preston holds 100,417 Ordinary Shares representing 0.28% of the total voting rights of the Company, as described below.

 

Total Voting Rights

 

Following the Exercise and also the earlier exercise of SAYE Options and receipt of employee vested share plan awards by certain other employees in the period since 16 October 2023, the Company is transferring or has transferred a total of 13,380 Ordinary Shares previously held in treasury to satisfy the transactions. As a result, the Company's issued share capital now consists of 35,542,169 Ordinary Shares, of which 179,082 remain held in treasury. Accordingly, the total number of Ordinary Shares in the Company with voting rights is 35,363,087. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

 

PDMR notification: Keith Neilson

 

1. Details of the Restricted Person / person closely associated with him or her

a) Name Keith Neilson

 

2. Reason for the notification

a) Position / status CEO

b) Initial notification / Amendment Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code ISIN GB00B2425G68

 

c) Nature of the transaction Exercise of options over Ordinary Shares

 

d) Price(s) and volume(s) Volume(s) 1,568 , Price(s) £11.475

 

e) Aggregated information: N/A (single transaction)

i. Aggregated volume -

ii. Price(s) -

f) Date of the transaction 2023-10-31

 

g) Place of the transaction Outside a trading venue

 

 

PDMR notification: Craig Preston

 

1. Details of the Restricted Person / person closely associated with him or her

a) Name Craig Preston

 

2. Reason for the notification

a) Position / status CFO

b) Initial notification / Amendment Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code ISIN GB00B2425G68

 

c) Nature of the transaction Exercise of options over Ordinary Shares

 

d) Price(s) and volume(s) Volume(s) 1,568, Price(s) £11.475

 

e) Aggregated information: N/A (single transaction)

i. Aggregated volume -

ii. Price(s) -

 

f) Date of the transaction 2023-10-31

 

g) Place of the transaction Outside a trading venue

 

 

 

For further information, please contact:

 

Craneware plc +44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma (Financial PR) +44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara Verdon craneware@almastrategic.com

Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900

Neil Patel, Paul Gillam, Richard Chambers, Kate Bannatyne

Investec Bank PLC (Joint Broker) +44 (0)20 7597 5970

Patrick Robb, Henry Reast, Cameron MacRitchie

Berenberg (Joint Broker) +44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons

 

About Craneware

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services" and is part of an extensive value cycle management suite. The Craneware Group - transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKDBNQBDDADK
Date   Source Headline
28th May 20124:11 pmRNSHolding(s) in Company
8th May 20125:41 pmRNSHolding(s) in Company
27th Apr 20125:09 pmRNSHolding(s) in Company
26th Apr 20124:17 pmRNSHolding(s) in Company
26th Apr 20123:46 pmRNSHolding(s) in Company
23rd Apr 20126:14 pmRNSTotal Voting Rights
23rd Apr 20126:13 pmRNSBlocklisting Interim Review
16th Apr 201212:57 pmRNSHolding(s) in Company
30th Mar 201212:36 pmRNSHolding(s) in Company
29th Mar 20125:02 pmRNSHolding(s) in Company
28th Mar 20123:39 pmRNSHolding(s) in Company
20th Mar 201212:12 pmRNSHolding(s) in Company
12th Mar 20125:51 pmRNSDividend Currency Election
8th Mar 201212:57 pmRNSHolding(s) in Company
5th Mar 201212:17 pmRNSTotal Voting Rights
2nd Mar 20123:24 pmRNSHolding(s) in Company
29th Feb 20125:43 pmRNSHolding(s) in Company
28th Feb 20124:29 pmRNSDirector/PDMR Shareholding
28th Feb 20127:00 amRNSChannel Partner Contract Win
28th Feb 20127:00 amRNSHalf Yearly Report
17th Feb 20123:29 pmRNSHolding(s) in Company
1st Feb 20127:00 amRNSNotice of Results
31st Jan 201210:00 amRNSHolding(s) in Company
16th Jan 20123:40 pmRNSHolding(s) in Company
12th Jan 20126:28 pmRNSHolding(s) in Company
11th Jan 20124:55 pmRNSHolding(s) in Company
10th Jan 20127:00 amRNSTrading Update
11th Nov 20111:14 pmRNSDividend Currency Election
10th Nov 201110:36 amRNSResult of AGM
10th Nov 20117:00 amRNSAGM Statement
1st Nov 20115:39 pmRNSTotal Voting Rights
1st Nov 201112:29 pmRNSBlocklisting Interim Review
25th Oct 20111:42 pmRNSDirector/PDMR Shareholding
18th Oct 20112:26 pmRNSPosting of Annual Report & Notice of AGM
30th Sep 20114:43 pmRNSTotal Voting Rights
26th Sep 20117:00 amRNSGrant of Options
31st Aug 201111:53 amRNSDirector/PDMR Shareholding
30th Aug 20117:00 amRNSFinal Results
22nd Aug 20115:02 pmRNSHolding(s) in Company
22nd Aug 20114:40 pmRNSSecond Price Monitoring Extn
22nd Aug 20114:35 pmRNSPrice Monitoring Extension
19th Aug 20114:40 pmRNSSecond Price Monitoring Extn
19th Aug 20114:35 pmRNSPrice Monitoring Extension
11th Aug 20113:49 pmRNSHolding(s) in Company
19th Jul 20117:00 amRNSTrading Update and Contract Wins
2nd Jun 20117:00 amRNSInvestor and Analyst Presentation
2nd Jun 20117:00 amRNSCraneware InSight Contract Win
31st May 201112:24 pmRNSTotal Voting Rights
24th May 20117:00 amRNSDirector Declaration
28th Apr 20112:42 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.